Validation of a zebrafish developmental defects assay as a qualified alternative test for its regulatory use following the ICH S5(R3) guideline
- PMID: 38016617
- DOI: 10.1016/j.reprotox.2023.108513
Validation of a zebrafish developmental defects assay as a qualified alternative test for its regulatory use following the ICH S5(R3) guideline
Abstract
Zebrafish is a popular toxicology model and provides an ethically acceptable small-scale analysis system with the complexity of a complete organism. Our goal is to further validate this model for its regulatory use for reproductive and developmental defects by testing the compounds indicated in the "Guideline on detection of reproductive and developmental toxicity for human pharmaceuticals" (ICH S5(R3) guideline.) To determine the embryotoxic and developmental risk of the 32 reference compounds listed in the ICH S5(R3) guideline, the presence of morphological alterations in zebrafish embryos was analyzed at two different stages to calculateLC50 and EC50 values for each stage. Teratogenic Indexes were established as the ratio between LC50 and EC50 critical for the proper compound classification as teratogenic when it is ≥ 2. A total of three biological replicates have been conducted to study the reproducibility of the assay. The chemicals' concentration in the medium and internally in the zebrafish embryos was evaluated. In this study, the 3 negative compounds were properly categorized while 23 compounds out of the 29 reference ones (sensitivity of 79.31%) were classified as teratogenic in zebrafish. The 6 that had false-negative results were classified 4 as inconclusive, 1 as not toxic, and 1 compound resulted toxic for zebrafish embryos under testing conditions. After the bioavailability experiments, some of the obtained inconclusive results were refined. The developmental defects assay in zebrafish gives an accuracy of 89.66%, sensitivity of 88.46%, specificity and repeatability of 100% compared to mammals; therefore, this is a well-integrated strategy using New Alternative Methods, to minimize the use of animals in developmental toxicity studies.
Keywords: Bench Marking Concentration (BMC); Bioavailability; Developmental defects; Embryotoxicity; ICH S5 (R3) Guideline; New alternative method (NAM); Zebrafish.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Arantza Muriana reports equipment, drugs, or supplies and writing assistance were provided by GAIKER. Arantza Muriana reports a relationship with GAIKER that includes: consulting or advisory. The author is co-founder and R&D Director of BBD BioPhenix SLU, and all the coauthors except Sainz L and De Goñi F are nowadays employed or have been employed previously by BBD BioPhenix SLU, a CRO specialized in the use of zebrafish for efficacy, toxicity and ecotoxicity assays, including offering teratogenicity, reprotoxicity, neurotoxicity, or endocrine disruption assays for Pharma Industry, Cosmetic Industry, or Agrochemical Industry, including the assays described in the paper. Sainz L and De Goñi F work in GAIKER, a company that BBD BioPhenix SLU outsources to develop bioavailability assays for their clients, in this case, they offered their services to analyze the compounds inside the zebrafish for this paper.
Similar articles
-
Validation of a new protocol for a zebrafish MEFL (malformation or embryo-fetal lethality) test method that conforms to the ICH S5 (R3) guideline.J Toxicol Sci. 2024;49(8):337-348. doi: 10.2131/jts.49.337. J Toxicol Sci. 2024. PMID: 39098043
-
Validation, Optimization, and Application of the Zebrafish Developmental Toxicity Assay for Pharmaceuticals Under the ICH S5(R3) Guideline.Front Cell Dev Biol. 2021 Sep 14;9:721130. doi: 10.3389/fcell.2021.721130. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34595173 Free PMC article.
-
Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo.Reprod Toxicol. 2009 Nov;28(3):308-20. doi: 10.1016/j.reprotox.2009.05.004. Epub 2009 May 15. Reprod Toxicol. 2009. PMID: 19447169
-
Using zebrafish in systems toxicology for developmental toxicity testing.Congenit Anom (Kyoto). 2016 Jan;56(1):18-27. doi: 10.1111/cga.12142. Congenit Anom (Kyoto). 2016. PMID: 26537640 Review.
-
The zebrafish embryotoxicity test (ZET) for nanotoxicity assessment: from morphological to molecular approach.Environ Pollut. 2019 Sep;252(Pt B):1841-1853. doi: 10.1016/j.envpol.2019.06.100. Epub 2019 Jun 28. Environ Pollut. 2019. PMID: 31325757 Review.
Cited by
-
Enhanced Stability and Detection Range of Microbial Electrochemical Biotoxicity Sensor by Polydopamine Encapsulation.Biosensors (Basel). 2024 Jul 26;14(8):365. doi: 10.3390/bios14080365. Biosensors (Basel). 2024. PMID: 39194594 Free PMC article.
-
Toxicokinetics of a developmental toxicity test in zebrafish embryos and larvae: Relationship with drug exposure in humans and other mammals.Curr Res Toxicol. 2024 Jul 14;7:100187. doi: 10.1016/j.crtox.2024.100187. eCollection 2024. Curr Res Toxicol. 2024. PMID: 39104612 Free PMC article.
-
Validation of a mouse 3D gastruloid-based embryotoxicity assay in reference to the ICH S5(R3) guideline chemical exposure list.Reprod Toxicol. 2024 Apr;125:108558. doi: 10.1016/j.reprotox.2024.108558. Epub 2024 Feb 15. Reprod Toxicol. 2024. PMID: 38367697
MeSH terms
Substances
LinkOut - more resources
Full Text Sources